Stock Movers

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Cardinal Health (CAH) forecast adjusted earnings per share for 2027; the guidance beat the average analyst estimate.
- US-listed shares in On Holding (ONON) drop after the Swiss sneaker maker’s second-quarter sales were lower than expected.
- Intel raised $20 billion in an upsized share sale, a third more than it was targeting when it announced the deal Monday morning.The chipmaker priced the offering at $95 per share, according to a company statement. That represents a discount of 6.5% to Friday’s closing price, according to Bloomberg calculations. The share sale drew more than $100 billion in demand, people familiar with the matter said.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Bellway shares fell as much as 1.6% after the homebuilder said annual underlying operating profit will hit the bottom-end of its guidance range.
- IWG shares fell as much as 11%, the most in almost a year, after the office company’s first half results showed an unexpected drop in free cash flow.
- Alcon shares rise as much as 6.6%, the most since November 2025, as the Swiss eye-care company delivers second-quarter results ahead of expectations and lifts guidance for core Ebit margin and EPS growth.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

- InterContinental Hotels reported pretax profit for the first half-year that beat the average analyst estimate.

- RBC initiates on the European defense sector, starting coverage of Leonardo, Rheinmetall and Thales with outperform ratings, and BAE Systems, CSG and Saab at sector perform.

- Alcon shares advance as much as 6.6%, the most since November 2025, as the Swiss eye-care company delivers second-quarter results ahead of expectations and lifts guidance for core Ebit margin and EPS growth.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

- Gan & Lee Pharmaceuticals shares rise alongside other Chinese weight loss-related stocks after the company signed an exclusive licensing deal with A. Menarini International to commercialize its obesity drug across 39 European markets.

- Yangzijiang Shipbuilding shares rise alongside other Singapore stocks as the city state upgraded its 2026 economic growth forecast.

- Samsung shares climb as much as 5.7% on expectations of a massive shareholder return package, which follow a boost in sentiment after the release of strong 10-day exports data.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market, a look at the notable movers:
On this episode of Stock Movers:

- Rocket Lab shares fell after it signaled a potential new delay with its Neutron rocket, raising the prospect that the vehicle won’t fly until 2027. The company stopped short of saying that the Neutron vehicle would fly this year, citing "risk and uncertainty remains in the complex development cycle". Rocket Lab reported record quarterly revenue but a loss that was a penny worse than Wall Street forecasted, with shares falling about 2% in US postmarket trading.

- Hims & Hers (HIMS) shares are down 2.9% after the telehealth firm reduced the top end of its adjusted Ebitda forecast for the full year.

- Nvidia (NVDA) announced partnerships with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to establish independent compute financing platforms mobilizing over $500b of third-party capital for AI infrastructure buildout
See omnystudio.com/listener for privacy information.